Latest News and Press Releases

Offering of $440 Million Ordinary Shares AMSTERDAM, The Netherlands, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced the commencement of a registered...

Will Add Unique PMA-Approved Technology for High Volume Foot & Ankle Procedure and Further Accelerate Growth Opportunities in Wright’s Extremities Business Purchase Price of $435 Million Cash ...

Second Quarter 2018 Net Sales of $205 Million Second Quarter 2018 Net Loss From Continuing Operations of $91 Million; Non-GAAP Adjusted EBITDA From Continuing Operations of $26 Million U.S. Upper...

Company Announces U.S. Launch of PROstep™ Minimally Invasive Surgery System Company Initiates U.S. Commercial Distribution and Sale of AUGMENT® Injectable Bone Graft AMSTERDAM, The Netherlands,...

AMSTERDAM, The Netherlands, July 11, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced that it will host a conference call on Wednesday, August 8, 2018, at 3:30 p.m....

AMSTERDAM, The Netherlands, June 21, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) (the “Company”) today announced that it has entered into privately negotiated agreements among...

Clinically Proven, Cost-Effective, Injectable Formulation of AUGMENT® Approved in U.S. for Ankle and/or Hindfoot Fusion Company Can Now Initiate Commercial Sale and Distribution in the U.S. Company...

AMSTERDAM, The Netherlands, May 29, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) announced today that it will present at the Jefferies Global Healthcare Conference on Thursday,...

AMSTERDAM, The Netherlands, May 17, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) announced today that it will present at the Jefferies Global Healthcare Conference on Thursday,...

First Quarter 2018 Net Sales of $199 Million First Quarter 2018 Net Loss From Continuing Operations of $20 Million; Non-GAAP Adjusted EBITDA From Continuing Operations of $27 Million U.S. Upper...